Your browser doesn't support javascript.
loading
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial.
Delahunt, B; Steigler, A; Atkinson, C; Christie, D; Duchesne, G; Egevad, L; Joseph, D; Kenwright, D N; Matthews, J; Murray, J D; Oldmeadow, C; Samaratunga, H; Spry, N A; Thunders, M C; Hondermarck, H; Denham, J W.
Afiliação
  • Delahunt B; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand. Electronic address: brett.delahunt@otago.ac.nz.
  • Steigler A; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
  • Atkinson C; St Georges Cancer Care Centre, Christchurch, New Zealand.
  • Christie D; Genesis Care, Tugun, Qld, Australia.
  • Duchesne G; Peter MacCallum Cancer Centre and University of Melbourne, Vic, Australia.
  • Egevad L; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
  • Joseph D; Sir Charles Gairdner Hospital, Perth, WA, Australia.
  • Kenwright DN; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.
  • Matthews J; Auckland City Hospital, Auckland, New Zealand.
  • Murray JD; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.
  • Oldmeadow C; Hunter Medical Research Institute, Newcastle, NSW, Australia.
  • Samaratunga H; Aquesta Uropathology and University of Queensland, Brisbane, Qld, Australia.
  • Spry NA; Genesis Care, Perth, WA, Australia.
  • Thunders MC; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.
  • Hondermarck H; Hunter Medical Research Institute, Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, NSW, Australia.
  • Denham JW; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
Pathology ; 54(1): 49-54, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34955242
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prognóstico / Neoplasias da Próstata / Adenocarcinoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prognóstico / Neoplasias da Próstata / Adenocarcinoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article